**Core tip:** One hundred and twenty-four patients with liver cancer were accepted therapy by argon-helium superconducting surgery system. Compared with 64-row group, guided scan times was longer and freezing effective rate for tumors \< 3 cm was lower in the dual-slice group. Four weeks after treatment, compared with dual-slice group, the hepatic artery perfusion and hepatic arterial perfusion index of tumor tissues were lower, the treatment effect and therapeutic efficacy in the 64-row group were higher. Complications were higher in the double-row group than in the 64-row group. 64-slice spiral computed tomography applied with cryoablation in targeted therapy for liver cancer can achieve a safe and effective freezing treatment.

INTRODUCTION
============

The incidence of liver cancer in China accounts for third place malignant tumors, and there has been an increasing trend in its incidence in recent years\[[@B1],[@B2]\]. In clinical practice, the best treatment for early liver cancer is the surgical resection of lesions. However, early symptoms of liver cancer are not obvious. Therefore, most patients diagnosed with liver cancer already developed and their tumors cannot be surgically removed or have poor surgical outcomes, and miss the opportunity for conventional radical surgery\[[@B3]-[@B6]\]. For patients with advanced tumors, if local treatment was available to delay the growth and spread of the tumor, it would help extend survival time and improve the quality of life of patients. With the development of minimally invasive treatments for tumors, these patients can be clinically given advanced cryoablation therapy at present\[[@B7]-[@B10]\]. Cryoablation targeted treatment has features such as a precise curative effect, easy to operate, safe and effective. This has gradually become an important method of minimally invasive treatment for liver cancer. Furthermore, imaging technology has been combined with the application of cryoablation during the course of treatment to observe tumor position and size, develop a preoperative puncture path, and for postoperative evaluation, of which computed tomography (CT) is widely used\[[@B11]-[@B14]\]. However, dual-slice spiral CT scanning technology has a long scan time and can't accurately position smaller tumors. As a guide during the cryosurgical treatment process, it may result in a smaller tumor omission. 64-slice spiral CT has a fast scanning speed and can provide clearer tumor positioning\[[@B15]\]. In order to better understand the application of 64-slice spiral CT during cryoablation, this study compared and analyzed the dual-slice spiral CT and 64-slice spiral CT guided cryosurgery treatments performed for liver cancer patients in our hospital; provide a reference for the clinical application of 64-slice spiral CT guided cryoablation therapy.

MATERIALS AND METHODS
=====================

General information
-------------------

A total of 124 patients with primary liver cancer, who were treated in our hospital from January 2014 to June 2016, were enrolled in this study. A total of 142 tumors were found from these patients. Among these patients, 83 patients were males and 41 patients were females; and the age of these patients ranged between 31-78 years, with a mean age of 54.5 ± 9.9 years. The diameter of the tumors ranged from 1.1 cm to 9.3 cm (6.3 ± 3.4 cm). In this study, the 124 patients were divided into two groups: dual-slice group and 64-slice group. Patients in the dual-slice group comprised of 56 patients (65 tumors) who underwent dual-slice spiral CT guided cryosurgery from January 2014 to March 2015. Among these patients, 38 were male and 18 were female, and the mean age of these patients was 52.4 ± 10.4 years. Furthermore, the tumor diameters ranged from 1.1 cm to 8.2 cm (6.2 ± 3.1 cm). Patients in the 64-slice group comprised 68 patients (77 tumors) who underwent 64-slice spiral CT guided cryosurgery from April 2015 to June 2016. Among these patients, 45 were male and 23 were female, and the mean age of these patients was 57.4 ± 9.5 years. Furthermore, the tumor diameters ranged from 1.3 to 9.3 cm (6.5 ± 3.6 cm). The difference in age, tumor diameter and other general information between these two groups of patients was not statistically significant (*P* \> 0.05).

Inclusion criteria: (1) patients with pathological examination-confirmed primary liver cancer; (2) elderly patients with heart and lung function not suitable for open surgery; (3) patients with liver function Child-Pugh grade A or B; (4) patients without severe hepatocellular jaundice and had a large number of ascites; and (5) patients with no serious coagulation dysfunction. This study was approved by the hospital ethics committee. All patients voluntarily chose cryoablation therapy, understood its importance, and provided a signed informed consent.

Methods
-------

In this study, 64-slice spiral CT guidance technology was Light Speed VCT; GE Company, United States, while the dual-slice spiral CT machine guidance instrument was Prospeed F-II; GE Company, United States. The two groups used the Magnetic Resonance-Compatible Cryotherapy System (Cryo-HIT) manufactured by Galileo, Israel. The surgical operations were performed by the same group of physicians. The patient's preoperative CT and other test results were used to determine the entry route, probe combined model and treatment range. Local anesthesia was performed on the puncture site after conventional disinfection, and intermittent CT scans were performed to observe the probe position and for timely adjustment. To determine the expected location of the needle on the tumor to start the ablation, first, the helium is frozen for 10-15 min. Then, re-warm the helium after three minutes. Repeat freezing and thaw once. Perform regular CT scans to detect iceball formation. Withdraw the frozen knife, hemostasis, and suture and bandaged up the puncture site.

A full perfusion examination of the liver was performed on patients three days before cryoablation treatment and four weeks after surgery in the Radiation Department of our hospital using Light Speed VCT (GE Company, United States). Preoperative preparation of CT perfusion include prothrombin time, blood biochemistry and other routine preoperative examinations, fasting for 4-6 h, and drinking 1000 mL of warm water 10-15 min before examination. An 18G standard intravenous catheter was placed at the right arm elbow anterior vein. The patient was encapsulated with an abdominal bandage and given breathing exercises, which were mainly chest breathing, supplemented by abdominal breathing. Precautions during the examination were explained to the patient.

Patients were placed in the supine foot first scan position. Before perfusion, patients were first given a routine abdominal plain scan to observe the liver and location of lesions, as well as the extent of the disease. Then, a dynamic volume scan was performed. Next, 40 mL of non-ion contrast agent iohexol and 30 mL of physiological saline (rate 5 mL/s) was administered through the intravenous indwelling needle in front of the elbow using a double-barreled high-pressure syringe. Then, the injection of the contrast agent was performed after eight seconds. The liver perfusion imaging picture obtained through the body perfusion software used dual input mode for analysis. Furthermore, hepatic artery perfusion (HAP), portal vein perfusion (PVP), and the hepatic arterial perfusion index (HAPI) perfusion parameter pseudo-color images were also obtained. Three region of interest (ROI) parameters of perfusion in the axial position, in the coronal and sagittal positions were randomly selected. Notice that the preoperative and postoperative selection of the region should be consistent, and mean values were calculated for the tumor, adjacent tumor and normal liver tissues. After four weeks, liver perfusion examination was carried out and an enhanced scan was performed, enhancement of the lesion was observed, and the local ablation of the tumor was evaluated.

Observation index
-----------------

CT-guided scan times were recorded and compared between the two groups of patients. Furthermore, the postoperative ice coverage range of ≥ 3 cm and \< 3 cm diameter tumors in the two groups were recorded. Then, the freezing effective rate was compared between the two groups. The liver perfusion values of tumor tissues, adjacent tumor tissues, and normal liver tissues between the two groups at preoperative and four weeks after cryoablation treatment were compared. Four weeks after surgery, local changes in the tumor were observed. The treatment was divided as follows: (1) complete ablation, complete necrosis of tumor tissues; (2) mostly ablated: lesion necrosis was \> 80%; (3) stable: tumor necrosis was \> 50%; and (4) progressive: increased mass or the emergence of newborn foci. The effective rate of the two groups was compared (complete ablation and major ablation). The clinical situation of these patients was closely observed. The following adverse reactions were recorded and compared between the two groups: fever, pain, skin frostbite, nausea, vomiting, pleural effusion, and abdominal bleeding.

Statistical analysis
--------------------

The data were analyzed using SPSS 17.0 software. Scanning time, hepatic perfusion (HAP, PVP and HAPI), and other measurement data were expressed as mean ± SD. *t*-test was used to compare the differences between the two groups. The freeze effective rate, effective rate of treatment after four weeks and the incidence of various adverse reactions that occurred and other count data were compared using the χ^2^-test between the two groups. The local therapeutic effects between the two groups were compared using the Mann-Whitney rank sum test. *P \<* 0.05 was considered statistically significant.

RESULTS
=======

Freezing effect of different diameter tumors in two groups
----------------------------------------------------------

In the two groups, a total of 142 lesions successfully underwent puncture and cryotherapy. Before treatment, the location and size of the tumor were observed by scanning to establish a reasonable puncture path. During cryosurgery, scanning was performed to guide the positioning of the puncture needle and to observe the postoperative changes of the tumor. As shown in Figures [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}, the guide-scan time for the dual-slice group (5.7 ± 1.8 min) was greater than that in the 64-slice group (2.8 ± 1.2 min); and the difference was statistically significant (*t =* 11.445, *P =* 0.000). Furthermore, the freeze effective rate of patients with tumor diameters \< 3 cm in the dual-slice group was significantly less than that in patients in the 64-slice group; and the difference was statistically significant (χ^2^ = 5.707, *P =* 0.017). Moreover, there was no significant difference in the freeze effective rate of patients with tumor diameters \> 3 cm between the two groups (χ^2^ = 0.236, *P =* 0.627); Table [1](#T1){ref-type="table"}.

###### 

Postoperative ice coverage of different tumor sizes

  **Groups**         **Tumor diameter (cm)**   **Number of tumors (count)**   **ice coverage (%)**   **Effective rate**            
  ------------------ ------------------------- ------------------------------ ---------------------- -------------------- -------- ----------------------------------------
  Dual-slice group   \< 3                      38                             19                     12                   7        81.58%
  ≥ 3                27                        17                             8                      2                    92.59%   
  64-slice group     \< 3                      42                             30                     9                    3        92.86%[a](#T1FN1){ref-type="table-fn"}
  ≥ 3                35                        26                             7                      2                    94.29%   

Effective rate = (ice coverage ≥ 80% of the tumor volume in the number of tumors)/(the total number of tumors) × 100%.

*P* \< 0.05, *vs* the dual-slice group.

![Before cryoablation, patients were placed in the prone position. Liver cancer chemoembolization after interventional therapy is shown, the lipiodol deposition area was the lesion tissue.](WJG-23-4080-g001){#F1}

![During cryoablation therapy, patients were placed in the prone position. The needle was placed to the right side of the abdominal wall and the puncture needle was positioned to the lesion bottom wall. The effective freezing area covered the lesions.](WJG-23-4080-g002){#F2}

![After the cryoablation treatment, the patient was placed in the prone position. The circular low-density area was the frozen necrotic area, which shows the lesions were within the range and it has good treatment effect.](WJG-23-4080-g003){#F3}

Comparison of liver perfusion values between the two groups
-----------------------------------------------------------

At four weeks after cryoablation treatment, CT perfusion examination was performed again to observe the change in liver perfusion value. The difference in HAP, PVP and HAPI before treatment in two groups was not statistically significant. In the two groups, HAP and HAPI levels in tumor tissues were lower after treatment than before treatment (*P \<* 0.05), and the difference was statistically significant (*P \<* 0.05). Furthermore, HAP and HAPI levels in the 64-slice group were lower than in the dual-slice group; and the difference was statistically significant (all *P \<* 0.05). HAP and PVP in the two groups were lower after treatment than before treatment, while HAPI increased; and the differences were statistically significant (all *P \<* 0.05). There was no significant difference in HAP, HAPI and PVP between the two groups after treatment (*P* \> 0.05). Furthermore, there was no significant difference in HAP, PVP and HAPI in normal liver tissues before and after treatment (all *P* \> 0.05; Table [2](#T2){ref-type="table"}).

###### 

Comparison of liver perfusion values before and after treatment (mean ± SD)

  **Tissue**               **64-slice group**                                                             **Dual-slice group**                                                                                                                                                                                                                                                         
  ------------------------ ------------------------------------------------------------------------------ ----------------------------------------------- ------------------------------------------------------------------------------ ---------------------------------------------- ----------------------------------------------- ---------------------------------------------- ---------------
  Tumor tissue             Pre-treatment                                                                  47.82 ± 16.71                                   8.51 ± 3.71                                                                    84.31 ± 13.22                                  48.42 ± 12.85                                   9.16 ± 3.75                                    82.27 ± 14.26
  Post-treatment           20.21 ± 9.42[a](#T2FN1){ref-type="table-fn"}[c](#T2FN2){ref-type="table-fn"}   8.13 ± 3.22                                     48.93 ± 9.42[a](#T2FN1){ref-type="table-fn"}[c](#T2FN2){ref-type="table-fn"}   26.21 ± 9.36[a](#T2FN1){ref-type="table-fn"}   8.53 ± 3.22                                     38.93 ± 9.42[a](#T2FN1){ref-type="table-fn"}   
  Adjacent tumor tissues   Pre-treatment                                                                  35.95 ± 15.25                                   47.81 ± 8.51                                                                   38.92 ± 16.91                                  35.95 ± 15.25                                   45.81 ± 8.51                                   37.92 ± 13.91
  Post-treatment           21.34 ± 9.95[a](#T2FN1){ref-type="table-fn"}                                   39.82 ± 14.33[a](#T2FN1){ref-type="table-fn"}   47.01 ± 9.71[a](#T2FN1){ref-type="table-fn"}                                   20.34 ± 9.95[a](#T2FN1){ref-type="table-fn"}   37.82 ± 14.33[a](#T2FN1){ref-type="table-fn"}   46.01 ± 9.71[a](#T2FN1){ref-type="table-fn"}   
  Normal liver tissue      Pre-treatment                                                                  25.65 ± 11.86                                   57.90 ± 18.93                                                                  28.62 ± 11.72                                  24.87 ± 13.48                                   58.93 ± 16.75                                  27.75 ± 14.68
  Post-treatment           26.02 ± 10.13                                                                  58.23 ± 16.94                                   27.43 ± 12.23                                                                  25.89 ± 10.78                                  59.78 ± 13.76                                   26.63 ± 12.25                                  

*P* \< 0.05, post-treatment *vs* pre-treatment in the group;

*P* \< 0.05, *vs* the dual-slice group post-treatment. HAP: Hepatic artery perfusion; PVP: Portal vein perfusion; HAPI: Hepatic arterial perfusion index.

Comparison of postoperative local treatment effect between the two groups
-------------------------------------------------------------------------

Patients in the two groups underwent CT perfusion imaging of the liver after four weeks to assess the therapeutic effect. In comparing these two groups, the treatment effect of patients in the 64-slice group was better than that observed in the dual-slice group; and the difference was statistically significant (*z* = -2.325, *P =* 0.020). Furthermore, the effective rate in the dual-slice double row group (76.93%) was lower than that in the 64-slice group (92.21%); and the difference was statistically significant (χ^2^ = 8.946, *P =* 0.003) (Table [3](#T3){ref-type="table"}).

###### 

Follow-up observation of treatment effect

  **Groups**         **Number of tumors (*n*)**   **Treatment effect (%)**   **Effective rate**                           
  ------------------ ---------------------------- -------------------------- -------------------- ------------ ---------- --------
  Dual-slice group   65                           42 (64.62)                 8 (12.31)            10 (15.38)   5 (7.69)   76.93%
  64-slice group     77                           62 (80.52)                 9 (11.69)            4 (5.19)     2 (2.60)   92.21%
  Test value         \-                           *z* = -2.325               χ^2^ = 8.946                                 
  *P* value          \-                           0.02                       0.003%                                       

Effective rate = (the number complete ablation cases + the number of mostly ablated cases)/ total number of tumors × 100%.

Incidence of post-operative adverse reactions
---------------------------------------------

In terms of post-operative adverse reactions, three patients had pleural effusion and two patients had intraperitoneal hemorrhage in the dual-slice group, however, these two complications did not occur in the 64-slice group, the difference between these two groups was statistically significant (*P \<* 0.05). Furthermore, fever rate was slightly higher in the 64-slice group than in the dual-slice group; but the difference was not statistically significant (*P* \> 0.05). The difference in pain, skin frostbite, nausea and vomiting between the two groups was not significant (*P* \> 0.05; Table [4](#T4){ref-type="table"}).

###### 

Postoperative adverse reactions *n* (%)

  **Group**          **Number of cases**   **Fever**    **Pain**    **Skin frostbite**   **Nausea and vomiting**   **Pleural effusion**   **Intraperitoneal hemorrhage**
  ------------------ --------------------- ------------ ----------- -------------------- ------------------------- ---------------------- --------------------------------
  Dual-slice group   56                    33 (53.57)   5 (8.93)    1 (1.79)             5 (8.93)                  3(5.36)                2(3.57)
  64-slice group     68                    43 (63.24)   7 (10.29)   1 (1.47)             6 (8.82)                  0                      0
  χ^2^               \-                    1.925        0.106       0.032                0                         5.508                  3.635
  *P* value          \-                    0.165        0.744       0.858                0.978                     0.019                  0.057

DISCUSSION
==========

For patients who cannot receive radical resection of liver cancer due to poor cardiopulmonary function or combined with extrahepatic metastasis or other factors, ablation therapy can not only removes the cancer cells, but also saves more normal liver function as much as possible. Furthermore, this treatment induces small physical trauma to patients\[[@B16]-[@B18]\]. Cryoablation therapy is a kind of local ablation therapy. With the development of technology in recent years, it has become one of the important means of minimally invasive treatment for liver cancer and other tumors\[[@B8],[@B19]\]. Cryoablation therapy is the combined application of ultra-low temperature and re-warming technology, in which tumor tissues are rapidly frozen and melted to damage tumor cells\[[@B20],[@B21]\]. With the right guidance technology, the frozen knife was placed in the tumor tissue; and high pressure argon and helium was successively input at room temperature. Argon at the tip of the knife was rapidly expanded, the tumor tissue was rapidly frozen to -140 °C, and helium which re-entered into the tumor tissue rapidly rise to 40-45 °C. During cryoablation, rapid freezing resulted in the production of intracellular ice crystals. This would destroy the osmotic balance inside and outside the cell membrane. Furthermore, due to cell volume expansion, extracellular ice crystals are formed, resulting in mutual extrusion and increased cell damage\[[@B22]-[@B24]\]. The melting immediate after the freezing causes the ice crystal balls to expand and burst, destroying the tumor cells. Then, after helium re-warms it to a certain extent, frozen ablation was carried out once again. This again damages tumor cells that have not been destroyed by the first cryoablation due to the dehydration of cells, increasing the destruction of tumor tissue\[[@B25],[@B26]\]. In the treatment of liver cancer, cryosurgery allows the accurate display of the tumor location and peripheral vascular conditions, which is important for an accurate puncture for cryotherapy and the right cryoablation area. Therefore, seeking for a good imaging technology to accurately display the location of the tumor and its surrounding tissue blood vessels can provide guidance in cryoablation treatment. That can significantly reduce damage to the surrounding tissues of the lesion and reduce postoperative complications\[[@B27]-[@B32]\]. At present, CT guidance has been widely used in the clinic. With the development of CT technology, 64-slice spiral CT has a high scanning speed, provides better resolution images, has a powerful 3D reconstruction capability that provides more intuitive images for the doctor, and can more clearly show the situation of blood vessels. This would help in understanding the relationship between the lesion and the surrounding blood vessels, observe whether blood vessels are within the liver variation, and avoid intraoperative variability vascular puncture accidental injury\[[@B33]-[@B36]\]. Therefore, this study compares and analyzes the cryosurgical treatment effects and complications between 64-slice spiral CT and double-slice spiral CT guidance, and try to observe whether 64-slice spiral CT-guided cryosurgery of the liver cancer can achieve better results.

Effect of cryotherapy in the two groups of patients
---------------------------------------------------

Comparing the scan time between the two groups of patients, it can be seen that the scan time of the 64-slice spiral CT is shorter, since the adjustment of the needle position during surgery and the observation of the formation of ice balls needs to be scanned several times, 64-slice spiral CT scan can help reduce scan waiting time; which speeds up the surgical process. The difference in freezing efficiency rate in tumor lesions ≥ 3 cm in diameter between the two groups was not statistically significant. However, the freezing efficiency rate was significantly greater in tumors \< 3 cm in diameter in the 64-slice group. 64-slice spiral CT-guided cryoablation have better results for smaller lesions.

This is because 64-slice spiral CT has higher spatial resolution, compared to dual-splice spiral CT. Furthermore, the 64-slice spiral CT enables the simultaneous collection of a 64-layer sub-millimeter thick image, and covers a long revolution of nearly 40 mm when it rotates in a circular course. In addition, it enables the reconstruction of the cross-section, coronal plane and other arbitrary plane images. The collected images are multi-planar imaging (MPR). That is, scanning is performed once, which can be adjusted in multiple directions. This enables an arbitrary slice image to be obtained, and helps in observing the details of the lesion and its spatial anatomy relationship. These advantages allow the 64-slice spiral CT to more clearly show the edge of the tumor and the formation of the edge of the ice ball during the surgery, help physicians control the ice ball range, and more clearly show the tumor tissue and its surrounding tissue. For smaller lesions, it can also clearly show the edge of the lesion and its adjacent vascular structure. Particularly near the diaphragm of the lesion, hilar large vessels and other special locations, the 64-slice spiral CT provides a clear image that enables physicians reduce intraoperative time, avoid damage to the surrounding normal tissues, and limits the freezing range; which affects the influence of the ablation\[[@B37]-[@B40]\]. 64-slice spiral imaging can directly reflect the internal hemodynamics of the liver, and has good reference value for understanding tumor angiogenesis and its biological characteristics \[[@B11],[@B41]-[@B44]\].

Evaluation of effects after four weeks of treatment
---------------------------------------------------

CT perfusion examination after four weeks revealed that HAP and HAPI decreased in tumor tissues in the two groups. However, these decreased more significantly in the 64-slice group, while the difference among HAP, HAPI and PVP between the two adjacent tissues and normal liver tissues was not statistically significant. The significant reduction in HAP and HAPI in the liver after treatment was an indicator of efficacy. This proves that lesion ablation treatment was better in patients in the 64-slice group. The presence of HAP in the tumor may represent the presence of arterial blood supply in the tumor, or the formation of postoperative granulation tissues with small blood vessels. In addition, liver cancer can easily recur and metastasize. Therefore, patients still need to be examined through continuous follow-ups. The effective rate in the 64-slice group was higher than that in the dual-slice group. The reason is that 64-slice spiral CT can provide good coverage of the ice ball for lesion with ≥ 3 cm and \< 3 cm diameters, and improve the ablation effect. Its three-dimensional imaging technology enables physicians to view liver blood vessels and lesions that are more solid, clear, more accurate, and more comprehensive; allowing a reasonable needle puncture and optimizing the freezing effect\[[@B11],[@B29],[@B45],[@B46]\]. Its rapid scan imaging during surgery allows the detection of the formation of ice ball and freezing conditions, provides an accurate lesion and surrounding tissue image, help in the timely adjustment of the ablation procedure, and prevents damage in surrounding tissues, while improving the effectiveness of tumor tissue ablation\[[@B9],[@B35],[@B47]\].

Incidence of postoperative complications in the two groups
----------------------------------------------------------

In the dual-slice group, three patients had pleural effusion and two patients had intraperitoneal hemorrhage. However, none of these complications occurred in patients in the 64-slice group. Furthermore, the difference between fever, pain, skin frostbite, nausea and vomiting occurring in patients in these two groups was not statistically significant. That proves 64-slice spiral CT can be used as a means of guidance, it has fewer postoperative complications, and its absence of pleural effusion and abdominal bleeding may be due to better liver blood vessel imaging technology. Compared to dual-slice spiral CT, 64-slice spiral CT can display a clearer visualization of the distribution of small blood vessels, allows the observation of the presence of variant blood vessels, and reduced the incidence of intraoperative vascular injury. Pleural effusion may occur due to tumors near the diaphragm, the intraoperative frozen stimulation to the diaphragm, or failure to monitor the extent of the frozen lesions in time; stimulating the pleura. The 64-slice spiral CT provides clear imaging, helps the surgeon accurately observe and control the freezing range, and reduces stimulation to the diaphragm and pleura\[[@B48]-[@B50]\].

However, in this study, only the treatment effect between 64-slice spiral CT-guided and dual-slice spiral CT-guided cryoablation were compared. At present, there is a need to further observe and compare the clinical applications of spiral CT, ultrasound, MRI and other guidance imaging technologies; and determine whether there is a difference in the guidance effect of these techniques when compared with 64-slice spiral CT. Furthermore, there is also a need to analyze the clinical applications the current guidance technologies, which has its own advantages; particularly in determining which technology has a better guiding treatment for patients with certain characteristics. In addition, this study followed-up patients up to four weeks after surgery. Future research should extend this follow-up time, in order to observe the recurrence and metastasis of liver cancer, as well as the survival time of patients of patients after treatment.

In conclusion, 64-slice spiral CT in the cryosurgical treatment of liver cancer targeting process provides a safe and effective freezing treatment. It is a reasonable choice worthy for clinical applications.

COMMENTS
========

Background
----------

Liver cancer is the third most common malignant tumour in China, and there has been an increasing trend in its incidence in recent years. For patients with advanced tumors, if local treatment is available to delay the growth and spread of the tumor, it would help extend survival time and improve the quality of life of patients. Cryoablation targeted treatment has gradually become an important method of minimally invasive treatment for liver cancer. The guide technology used in argon-helium cryoablation therapy includes double-row spiral computed tomography (CT) and 64-slice spiral CT and so on. To compare the dual-slice spiral CT and 64-slice spiral CT guided cryosurgery treatments performed for liver cancer patients can provide a reference for the clinical application of 64-slice spiral CT guided cryoablation therapy.

Research frontiers
------------------

In the treatment of liver cancer, cryosurgery allows the accurate display of the tumor location and peripheral vascular conditions, which is important for an accurate puncture for cryotherapy and the right cryoablation area. The 64-slice spiral CT has a high scanning speed, provides better resolution images, and has a powerful 3D reconstruction capability that provides more intuitive images for the doctor. Therefore, the authors hope that this technology in the guidance of argon helium cryo-knife treatment has a good effect.

Innovations and breakthroughs
-----------------------------

The 64-slice spiral CT has higher spatial resolution. For smaller lesions, it can also clearly show the edge of the lesion and its adjacent vascular structure. The 64-slice spiral CT provides a clear image that enables physicians to reduce intraoperative time, avoiding damage to the surrounding normal tissues. This means that guidance of argon-helium cryosurgery treatment of small diameter liver cancer also has a good freezing effect. It has an important clinical application value and is worthy of promoting.

Applications
------------

In this study, compared with the double-row group, the guide scan time is short and more efficient in tumors \< 3 cm in diameter in the 64-slice group. Four weeks after treatment, the treatment effect and treatment efficiency is better, less complications in the 64-slice group. Therefore, it is recommended to use 64-slice spiral CT in the treatment of liver cancer by argon helium cryoablation.

Peer-review
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This an interesting manuscript. In this manuscript, the effect of targeted therapy of 64-slice spiral CT combined with cryoablation for liver cancer was observed. A total of 124 patients were enrolled into this study. According to the use of dual-slice spiral CT or 64-slice spiral CT as a guide technology, patients were divided into two groups: dual-slice group and 64-slice group. All the patients were accepted for the targeted therapy by argon-helium superconducting surgery system. The guided scan times of the two groups was recorded and compared. The authors found that the treatment effect and therapeutic efficacy in the dual-slice group were lower than the 64-slice group at four weeks post-treatment.
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